The most common cause of dementia among older people, Alzheimer's disease, currently has no effective drugs to stop, slow or prevent disease progression. A study online December 5th in the ISSCR's journal iStem Cell Reports/i, published by Cell Press, provide interesting clues on why non-steroidal anti-inflammatory drugs (NSAIDs), which have successfully treated molecular signs of Alzheimer's disease in cell and animal models, eventually failed in clinical studies. ...
Read MoreYou have just read an article categorized health
titled Why Promising Dementia Drugs Failed in Clinical Trials Explained.
Written by:
editor - Sunday, December 8, 2013
There are currently no comments for "Why Promising Dementia Drugs Failed in Clinical Trials Explained"
Post a Comment